Drugs / Cadisurf
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02774044 | Jun 2016 → Feb 2019 | respiratory distress syndrome in premature infants | Ramesh K Agarwal | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cadisurf | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02774044 ↗ |
| Route | Other | “Neonates in the intervention group will be intratracheally administered 100 mg/kg of GLSE (CADISURF®).” NCT02774044 ↗ |